Literature DB >> 17462600

Involvement of Rabring7 in EGF receptor degradation as an E3 ligase.

Ayuko Sakane1, Shigetsugu Hatakeyama, Takuya Sasaki.   

Abstract

Rab7, a member of the Rab family small G proteins, is involved in the late stage of the endocytic pathway. We previously identified a Rab7 target protein, Rabring7, which contains a RING finger domain at its C termini, but the precise role of Rabring7 remains unknown. In this study, we demonstrate using an in vitro ubiquitination assay with recombinant E1 and E2 proteins that Rabring7 has E3 ligase activity and that it preferentially reacts with Ubc4 and Ubc5 as its E2 proteins. Rabring7 ubiquitinated itself but not Rab7, and a mutation at Cys-229 in the RING finger domain (Rabring7C229S) completely diminished its E3 ligase activity. In the ligand-induced degradation of EGF receptor (EGFR), Rabring7 accelerated the degradation of EGFR, whereas Rabring7C229S inhibited the degradation induced by cCbl, another E3 ligase. These results suggest that Rabring7 is involved in the endocytic trafficking of EGFR through its E3 ligase activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462600     DOI: 10.1016/j.bbrc.2007.04.052

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Ubiquitination: Added complexity in Ras and Rho family GTPase function.

Authors:  Michelle de la Vega; James F Burrows; James A Johnston
Journal:  Small GTPases       Date:  2011-07-01

2.  Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer.

Authors:  Ghali Brahemi; Fathima R Kona; Annalisa Fiasella; Daniela Buac; Jitka Soukupová; Andrea Brancale; Angelika M Burger; Andrew D Westwell
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

Review 3.  Multifaceted Roles of the E3 Ubiquitin Ligase RING Finger Protein 115 in Immunity and Diseases.

Authors:  Mei-Xia Wang; Tianzi Liuyu; Zhi-Dong Zhang
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

4.  Autoubiquitination of BCA2 RING E3 ligase regulates its own stability and affects cell migration.

Authors:  Yutaka Amemiya; Peter Azmi; Arun Seth
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

Review 5.  Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities.

Authors:  J O Agola; P A Jim; H H Ward; S Basuray; A Wandinger-Ness
Journal:  Clin Genet       Date:  2011-07-13       Impact factor: 4.438

6.  Rab7A is required for efficient production of infectious HIV-1.

Authors:  Marina Caillet; Katy Janvier; Annegret Pelchen-Matthews; Delphine Delcroix-Genête; Grégory Camus; Mark Marsh; Clarisse Berlioz-Torrent
Journal:  PLoS Pathog       Date:  2011-11-03       Impact factor: 6.823

7.  Expansion and diversification of BTL ring-H2 ubiquitin ligases in angiosperms: putative Rabring7/BCA2 orthologs.

Authors:  Victor Aguilar-Hernández; Juliana Medina; Laura Aguilar-Henonin; Plinio Guzmán
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

8.  BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction.

Authors:  Kei Miyakawa; Akihide Ryo; Tsutomu Murakami; Kenji Ohba; Shoji Yamaoka; Mitsunori Fukuda; John Guatelli; Naoki Yamamoto
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

9.  Rabring7 degrades c-Myc through complex formation with MM-1.

Authors:  Rina Narita; Hirotake Kitaura; Ayako Torii; Erika Tashiro; Makoto Miyazawa; Hiroyoshi Ariga; Sanae M M Iguchi-Ariga
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  Regulation of retromer recruitment to endosomes by sequential action of Rab5 and Rab7.

Authors:  Raul Rojas; Thijs van Vlijmen; Gonzalo A Mardones; Yogikala Prabhu; Adriana L Rojas; Shabaz Mohammed; Albert J R Heck; Graça Raposo; Peter van der Sluijs; Juan S Bonifacino
Journal:  J Cell Biol       Date:  2008-11-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.